HRP930803A2 - Fluorinated hydroxyalkylquinoline acids as leukortine antagonists - Google Patents

Fluorinated hydroxyalkylquinoline acids as leukortine antagonists Download PDF

Info

Publication number
HRP930803A2
HRP930803A2 HR930803A HRP930803A HRP930803A2 HR P930803 A2 HRP930803 A2 HR P930803A2 HR 930803 A HR930803 A HR 930803A HR P930803 A HRP930803 A HR P930803A HR P930803 A2 HRP930803 A2 HR P930803A2
Authority
HR
Croatia
Prior art keywords
antagonists
formula
compound
compound according
compounds
Prior art date
Application number
HR930803A
Other languages
English (en)
Croatian (hr)
Inventor
Robert Zamboni
Daniel Guay
Marc Labelle
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of HRP930803A2 publication Critical patent/HRP930803A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR930803A 1992-04-10 1993-04-09 Fluorinated hydroxyalkylquinoline acids as leukortine antagonists HRP930803A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/866,690 US5270324A (en) 1992-04-10 1992-04-10 Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
CN92105948A CN1080169A (zh) 1992-04-10 1992-06-16 含有水溶性药物的控释片

Publications (1)

Publication Number Publication Date
HRP930803A2 true HRP930803A2 (en) 1994-12-31

Family

ID=25742768

Family Applications (1)

Application Number Title Priority Date Filing Date
HR930803A HRP930803A2 (en) 1992-04-10 1993-04-09 Fluorinated hydroxyalkylquinoline acids as leukortine antagonists

Country Status (21)

Country Link
US (1) US5270324A (de)
EP (1) EP0565185B1 (de)
JP (1) JP2504687B2 (de)
CN (2) CN1080169A (de)
AT (1) ATE168100T1 (de)
AU (1) AU653476B2 (de)
BG (1) BG62402B1 (de)
CA (1) CA2092896C (de)
CZ (1) CZ246394A3 (de)
DE (1) DE69319482T2 (de)
ES (1) ES2117691T3 (de)
FI (1) FI944734L (de)
HR (1) HRP930803A2 (de)
HU (1) HU218917B (de)
IL (1) IL105193A0 (de)
LV (1) LV12290B (de)
MX (1) MX9302033A (de)
NO (1) NO943792L (de)
SI (1) SI9300188A (de)
WO (1) WO1993021159A1 (de)
ZA (1) ZA932533B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
GB9216768D0 (en) * 1992-08-07 1992-09-23 Leo Pharm Prod Ltd Chemical compounds
ES2080656B1 (es) * 1993-07-19 1996-10-16 Merck Frosst Canada Inc Acidos de hidroxialquilquinolina fluorados como antagonistas del leucotrieno.
CA2130723C (en) * 1993-09-03 2006-01-31 Wilhelm Quittmann Process for preparing y-mercaptocarboxylic acid derivatives
DE4339724C1 (de) * 1993-11-22 1995-01-19 Siemens Ag Gasarmatur
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
US5491077A (en) * 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
US5427933A (en) * 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
GB9415997D0 (en) * 1994-08-08 1994-09-28 Merck Sharp & Dohme Therapeutic agents
US5545758A (en) * 1994-08-11 1996-08-13 Merck & Co., Inc. Process for the preparation of diisopinocampheylchloroborane
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5648448A (en) * 1995-06-06 1997-07-15 Hitachi Chemical Company, Ltd. Method of preparation of polyquinolines
US5750539A (en) * 1995-06-07 1998-05-12 Merck Frosst Canada Heteroaryl diol acids as leukotriene antagonists
EE9800234A (et) * 1996-02-08 1998-12-15 Merck & Co., Inc. Ravimeetod ja farmatseutiline kompositsioon
PL193131B1 (pl) * 1997-12-23 2007-01-31 Schering Corp Kompozycja farmaceutyczna zawierająca kombinację składników aktywnych i jej zastosowanie
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US6696466B1 (en) 2000-09-07 2004-02-24 Leslie Joe Dunaway Methods of treating select neuronal inflammatory disorders using hydroxyalkylquinolines
CA2371048C (en) 2002-02-06 2011-01-04 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
EP1507106B1 (de) * 2003-08-15 2007-07-18 ABB Turbo Systems AG Rotationsdichtung
ATE522507T1 (de) * 2003-10-10 2011-09-15 Synhton B V Montelukast in fester phase
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
EP1819329A2 (de) * 2004-08-04 2007-08-22 Schering Corporation Pharmazeutische formulierungen mit pleconaril zur behandlung von atemwegserkrankungen
JP2008517938A (ja) 2004-10-25 2008-05-29 シェーリング コーポレイション 呼吸器障害を処置するために他の活性剤と組み合わせたｍ１レセプターアンタゴニストおよび／またはｍ３レセプターアンタゴニスト
US20070161796A1 (en) * 2005-11-16 2007-07-12 Ilan Kor-Sade Drying methods of montelukast sodium by azeotropic removal of the solvent
AR057908A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast e intermediarios del mismo
WO2007107297A1 (en) * 2006-03-17 2007-09-27 Synthon B.V. Montelukast amantadine salt
US20090326232A1 (en) * 2006-06-26 2009-12-31 Uttam Kumar Ray Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium)
KR20090026217A (ko) * 2006-07-11 2009-03-11 쉐링 코포레이션 치환된 5-옥사졸-2-일-퀴놀린 화합물의 크시나포에이트 염
US7271268B1 (en) 2006-12-22 2007-09-18 Formosa Laboratories Inc. Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
PL205444B1 (pl) * 2007-05-02 2010-04-30 Zak & Lstrok Ady Farmaceutyczn Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego
WO2009117381A2 (en) * 2008-03-17 2009-09-24 Dr. Reddy's Laboratories Ltd. Preparation of montelukast and its salts
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
JP2012530140A (ja) 2009-06-16 2012-11-29 メルク・シャープ・アンド・ドーム・コーポレーション グルココルチコイド受容体アゴニストとしての新規［３，２−ｃ］ヘテロアリールステロイド、組成物およびこの使用
CA2842881A1 (en) * 2011-07-26 2013-04-11 Rajendrasinh RATHOD Cysteinyl leukotriene antagonists
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN105085391B (zh) 2015-06-10 2017-08-22 广东默泰同创医药科技有限公司 用作白三烯受体拮抗剂的环丙基不饱和喹啉化合物及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
IE861607L (en) * 1985-06-18 1986-12-18 Bunce Roger A 2-substituted quinolines
US4851409A (en) * 1986-02-14 1989-07-25 Merck Frosst Canada Inc. 2-substituted quinoline dioic acids and pharmaceutical compositions
IE59889B1 (en) * 1986-02-14 1994-04-20 Merck Frosst Canada Inc 2-substituted quinoline dioic acids
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
FR2617352B1 (fr) * 1987-06-26 1989-12-01 Eduvision Sa Procede de codage de donnees informatiques pour transmission aux normes video, videodisque mettant en oeuvre ledit procede et interface d'exploitation d'un tel videodisque
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
IL88433A0 (en) * 1987-11-25 1989-06-30 Merck Frosst Canada Inc Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
NZ233752A (en) * 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
ATE165088T1 (de) * 1990-10-12 1998-05-15 Merck Frosst Canada Inc Ungesättigte hydroxyalkylchinolinsäuren als leukotrien-antagonisten
IE920499A1 (en) * 1991-02-21 1992-08-26 Merck Frosst Canada Inc Quinoline-containing ketoacids as leukotriene antagonists

Also Published As

Publication number Publication date
EP0565185B1 (de) 1998-07-08
FI944734A7 (fi) 1994-10-07
HUT70399A (en) 1995-10-30
BG99085A (bg) 1995-06-30
FI944734A0 (fi) 1994-10-07
HU9402905D0 (en) 1995-01-30
CN1043761C (zh) 1999-06-23
US5270324A (en) 1993-12-14
LV12290B (en) 1999-11-20
DE69319482T2 (de) 1999-02-04
ATE168100T1 (de) 1998-07-15
CA2092896A1 (en) 1993-10-11
WO1993021159A1 (en) 1993-10-28
MX9302033A (es) 1994-07-29
CN1083052A (zh) 1994-03-02
JPH0625173A (ja) 1994-02-01
FI944734L (fi) 1994-10-07
NO943792L (no) 1994-12-08
AU653476B2 (en) 1994-09-29
ES2117691T3 (es) 1998-08-16
CZ246394A3 (en) 1996-01-17
CA2092896C (en) 2005-12-20
BG62402B1 (bg) 1999-10-29
AU3686393A (en) 1993-10-14
HU218917B (hu) 2000-12-28
ZA932533B (en) 1993-11-04
EP0565185A1 (de) 1993-10-13
IL105193A0 (en) 1993-07-08
JP2504687B2 (ja) 1996-06-05
LV12290A (lv) 1999-06-20
NO943792D0 (no) 1994-10-07
CN1080169A (zh) 1994-01-05
DE69319482D1 (de) 1998-08-13
SI9300188A (sl) 1993-12-31

Similar Documents

Publication Publication Date Title
CA2092896C (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
US5952347A (en) Quinoline leukotriene antagonists
EP0535925B1 (de) (Bicyclische Heteroarylmethoxy)indole als Inhibitore leukotriene Biosynthese
CA1333714C (en) Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis
CA2047858C (en) (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
US5093356A (en) Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
WO1993025546A1 (en) Bicyclic(azaaromatic)indoles as inhibitors of leukotriene biosynthesis
EP0535924A1 (de) (Bizyklische-Azaarylmethoxy)Indole als Inhibitoren der Leukotrien-Biosynthese
EP0535923A1 (de) (Azaarylmethoxy)indole als Inhibitore der Leukotriene Biosynthese
EP0480716A1 (de) Gesättigte Hydroxyalkylchinolinsäuren zur Verwendung als Leukotrien-Antagonisten
EP0500360B1 (de) Chinoline enthaltende Ketosäure als Leukotrien-Antagonisten
EP0468789A2 (de) (Chinolin-2-ylmethoxy)heterotetrahydrocarbazole als Inhibitoren der Leukotrienen-Biosynthese
WO1993021168A1 (en) Thiazole-substituted benzyl alcohols as leukotriene antagonists
US5438141A (en) Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists
US5334597A (en) Indole carbamates as leukotriene antagonists
US5149703A (en) Quinoline-substituted chromans and related compounds as leukotriene antagonists
US5750539A (en) Heteroaryl diol acids as leukotriene antagonists
CA2283101C (en) Quinoline leukotriene antagonists
US5350760A (en) Aza-5,5-fused hetrocyclic acids as leukotriene antagonists
WO1993021169A1 (en) Benzothiazole-substituted benzyl alcohols as leukotriene antagonists
RU2143426C1 (ru) Хинолин-производные и фармацевтическая композиция на их основе, проявляющая активность антагониста лейкотриена
US5212180A (en) Quinoline-containing ketoacids as leukotriene antagonists
WO1994005658A1 (en) Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
CA2007786C (en) Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
CA2223414C (en) Heteroaryl diol acids as leukotriene antagonists

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
OBST Application withdrawn